Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study.

OBJECTIVE--To compare the efficacy, tolerance and safety of 50-150 micrograms orally administered iloprost given twice a day versus placebo in patients with Raynaud's syndrome. METHODS--The study was multicentre (n = 3), double blind and placebo controlled. Sixty three patients who had eight or...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Belch, J J, Capell, H A, Cooke, E D, Kirby, J D, Lau, C S, Madhok, R, Murphy, E, Steinberg, M
Médium: Artigo
Jazyk:Inglês
Vydáno: 1995
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1005556/
https://ncbi.nlm.nih.gov/pubmed/7538285
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky